Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer

Hypertension

Volumn 59, Issue 2, 2012, Pages 205-211

  Jung, Su Yon ^a   Rosenzweig, Margaret ^c,d   Linkov, Faina ^a,b   Brufsky, Adam ^b,c   Weissfeld, Joel L ^a,b,c   Sereika, Susan M ^a,d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Advanced breast cancer; Comorbidity; Hypertension; Mediation

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER PATIENT; CANCER SURVIVAL; CEREBROVASCULAR DISEASE; CHRONIC LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DEMENTIA; DIABETES MELLITUS; FEMALE; HEALTH DISPARITY; HEART INFARCTION; HEMIPLEGIA; HUMAN; HYPERTENSION; KIDNEY DISEASE; LEUKEMIA; LIVER DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; METASTATIC BREAST CANCER; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; ULCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84856285306     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.171736     Document Type: Article

References (42)

1. Surveillance Epidemiology and End Results Program (SEER). SEER Stat Database:SEER Stat Fact Sheets. 2008. http://www.seer.cancer.gov.
2. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA: Cancer J Clinicians. 1995;45:8-30.
3. Handerson IC, Harris JR, Kinne DW. Cancer of the breast. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. 3rd edition. Philadelphia, PA: Lippincott; 1989;1197-1268.
4. Kessler LG. The relationship between age and incidence of breast cancer: population and screening program data. Cancer. 1992;69:1896-1903.
5. Fleming ID, Fleming MD. Breast cancer in elderly women. Cancer. 1994;74:2160-2164. (Pubitemid 24304389)
6. Bergman L, Dekker G, van Leeuwen FE, Huisman SJ, van Dam FS, van Dongen JA. The effect of age on treatment choice and survival in elderly breast cancer patients. Cancer. 1991;67:2227-2234.
7. Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F, Birtwisle-Peyrottes I, Balu-Maestro C, Marcy PY, Raoust I, Lallement M, Chamorey E. Prognostic factors in 1, 038 women with metastatic breast cancer. Ann Oncol. 2008;19:2012-2019.
8. Cluze C, Colonna M, Remontet L, Poncet F, Sellier E, Seigneurin A, Delafosse P, Bossard N. Analysis of the effect of age on the prognosis of breast cancer. Breast Cancer Res Treatment. 2009;117:121-129.
9. Bergman L, Dekker G, van Kerkhoff EH, Peterse HL, van Dongen JA, van Leeuwen FE. Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Res Treatment. 1991;18:189-198.
10. Fleming ST, Rastogi A, Dmitrienko A, Johnson KD. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care. 1999;37:601-614.
11. Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA, Coebergh JW. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer. 2005;41:779-785. (Pubitemid 40347298)
12. Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P, Kurtz J, Sappino AP, Vlastos G. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 2003;21:3580-3587. (Pubitemid 46594049)
13. Yancik R, Havlik RJ, Wesley MN, Ries L, Long S, Rossi WK, Edwards BK. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol. 1996;6:399-412. (Pubitemid 26372528)
14. Cronin-Fenton DP, Norgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sorensen HT. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer. 2007;96:1462-1468. (Pubitemid 46685783)
15. Houterman S, Janssen-Heijnen ML, Verheij CD, Louwman WJ, Vreugdenhil G, van der Sangen MJ, Coebergh JW. Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer. 2004;90:2332-2337. (Pubitemid 38961896)
16. Harlan LC, Klabunde CN, Ambs AH, Gibson T, Bernstein L, McTiernan A, Meeske K, Baumgartner KB, Ballard-Barbash R. Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. J Cancer Surviv. 2009;3:89-98.
17. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009;124:1213-1219.
18. Smith BD, Haffty BG, Hurria A, Galusha DH, Gross CP. Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol. 2006;24:4901-4907. (Pubitemid 46630918)
19. Girones R, Torregrosa D, Diaz-Beveridge R. Comorbidity, disability and geriatric syndromes in elderly breast cancer survivors: results of a singlecenter experience. Crit Rev Oncol/Hematol. 2010;73:236-245.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
21. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294:1765-1772. (Pubitemid 41434622)
22. Do KA, Treloar SA, Pandeya N, Purdie D, Green AC, Heath AC, Martin NG. Predictive factors of age at menopause in a large Australian twin study. Hum Biol Int Record Res. 1998;70:1073-1091. (Pubitemid 28532143)
23. US National Institutes of Health, National Institute on Aging. AgePage Menopause: National Institute on Aging National Institutes of Health US. Department of Health and Human Services. 2008.
24. Clark GM. The biology of breast cancer in older women. J Gerontol. 1992;47:19-23.
25. Census 2000 summary file 3 (SF 3). US Census Bureau; 2000. http://fact finder.census.gov/servlet/DatasetMainPageServlet?-program=DEC&-tabId= DEC1&-submenuId=datasets-1&-lang=en&-ts=304686297161.
26. American Heart Association. What Is High Blood Pressure? 2009. http://www.americanheart.org/presenter.jhtml?identifier = 2114. Accessed August 1, 2009.
27. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
28. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc Series B (Methodological). 1977;39:1-38.
29. Hosmer DW Jr, Lemeshow S. Applied Survival Analysis. London: Wiley Interscience; 1999.
30. Judd CM, Kenny DA. Process analysis estimating mediation in treatment evaluations. Evaluation Rev. 1981;5:602-619.
31. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Person Social Psychol. 1986;51:1173-1182.
32. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36:717-731. (Pubitemid 40251423)
33. MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. 2007;58:593-614.
34. Tein J, MacKinnon D. Estimating mediated effects with survival data. In: Yanai H, Rikkyo A, Shigemasu K, Kano Y, Meulman J, eds. New Developments in Psychometrics. Tokyo: Springer-Verlag; 2003;405-412.
35. Mackinnon DP, Warsi G, Dwyer JH. A simulation study of mediated effect measures. Multivariate Behav Res. 1995;30:41.
36. Kimmick GG, Balducci L. Breast cancer and aging: clinical interactions. Hematol/Oncol Clin North Am. 2000;14:213-234. (Pubitemid 30078439)
37. Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H. Hypertension, diuretics and breast cancer risk. J Hum Hypertens. 2006;20:727-732. (Pubitemid 44430670)
38. Hamet P. Cancer and hypertension: an unresolved issue. Hypertension. 1996;28:321-324. (Pubitemid 26296028)
39. Dyer AR, Stamler J, Berkson DM, Lindberg HA, Stevens E. High bloodpressure: a risk factor for cancer mortality? Lancet. 1975;1:1051-1056.
40. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291:2441-2447. (Pubitemid 38669187)
41. Goon PK, Messerli FH, Lip GY. Hypertension and breast cancer: an association revisited? J Hum Hypertens. 2006;20:722-724. (Pubitemid 44430668)
42. Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer. 2003;98:1504-1513. (Pubitemid 37151507)